Portola Pharmaceuticals Inc (PTLA) Return on Assets ROA from the first quarter of 2020 to first quarter of 2019 and for the year 2020, Average High and Low, Fundamental Ratios from Mar 31 2020 to Mar 31 2019 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Portola Pharmaceuticals inc   (NASDAQ: PTLA)


Portola Pharmaceuticals Inc 's ROA from the first quarter of 2020 to the first quarter of 2019 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Portola Pharmaceuticals Inc 's ROA in the first quarter of 2020?
Portola Pharmaceuticals Inc recorded a cumulative net loss of $-284 million during 12 months ending in the first quarter of 2020, resulting in a negative return on assets (ROA) of -55.9%.

However, within the Healthcare sector 604 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2020 quarter, so far to 4310, from total ROA ranking in the fourth quarter of 2019 at 4873.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter
Y / Y Total Assets Change 39.49 % 56.72 % 35.2 % -28.5 % -25.38 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -284 -293 -285 -307 -344
Return On Assets (TTM) -55.9 % -62.18 % -68.02 % -80.36 % -82.31 %
PTLA's Total Ranking # 4310 # 4873 # 4419 # 4523 # 4599
Total Assets (TTM) in million 512 573 577 366 367
Seq. Total Assets Change -10.71 % -0.66 % 57.49 % -0.14 % 0.32 %
Seq. Net Income Change - - - - -

PTLA's 5 Years Annual ROA >> Back to PTLA Management Effectiveness >> Compare PTLA ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 276
Sector # 605
Overall # 4162

Return On Assets Statistics
High Average Low
53.06 %
-46.1 %
-78.79 %
(Dec 31 2013)   (Mar 31 2019)





Financial Statements
Portola Pharmaceuticals Inc 's Assets $ 512 million PTLA's Balance sheet
Portola Pharmaceuticals Inc 's Income $ -69 million Quarterly PTLA's Income Statement
PTLA's Income by Division See PTLA's Income by Division



Annual Return On Assets (Dec 31 2019)
FY 2019		 (Dec 31 2018)
FY 2018		 (Dec 31 2017)
FY 2017		 (Dec 31 2016)
FY 2016		 (Dec 31 2015)
FY 2015
Y / Y Total Assets Change 58.12 % -34.91 % 66.18 % -31.11 % 22.46 %
Total Assets in million 578 366 562 338 491
Y / Y Net Income Change - - - - -
Net Income in million -293 -351 -286 -268 -227
Annual Return On Assets -50.63 % -95.82 % -50.82 % -79.27 % -46.14 %

PTLA's 5 Years Annual ROA >> Back to PTLA Management Effectiveness >> Compare PTLA ROA to its Competitors



More Return On Assets Ratios
PTLA's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
PTLA's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for PTLA's Competitors
Subscribers only: Roa for Portola Pharmaceuticals Inc 's Suppliers
Subscribers only: Return On Assets for PTLA's Customers

You may also want to know
PTLA's Roi PTLA's Inventory Turnover Ratio PTLA's Growth Rates PTLA's Dividend Comparisons
PTLA's Profitability Ratios PTLA's Asset Turnover Ratio PTLA's Dividend Growth
PTLA's Roe PTLA's Valuation Ratios PTLA's Financial Strength Ratios PTLA's Dividend Payout Ratio



Companies with similar Return On Assets at Mar 31 2020, within Healthcare Sector ROA

Date modified: 2026-09-08T15:09:56+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.